I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 4 studies | 32% ± 15% | |
| glutamatergic neuron | 4 studies | 39% ± 18% | |
| neuron | 3 studies | 24% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 4 studies | 32% ± 15% | |
| glutamatergic neuron | 4 studies | 39% ± 18% | |
| neuron | 3 studies | 24% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 30% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 827.11 | 245 / 245 | 100% | 20.45 | 502 / 502 |
| brain | 100% | 1976.25 | 2641 / 2642 | 100% | 37.20 | 704 / 705 |
| kidney | 100% | 872.34 | 89 / 89 | 98% | 16.13 | 883 / 901 |
| adrenal gland | 98% | 581.40 | 254 / 258 | 99% | 31.10 | 228 / 230 |
| pancreas | 99% | 455.63 | 325 / 328 | 98% | 11.39 | 174 / 178 |
| ovary | 99% | 832.42 | 179 / 180 | 97% | 12.25 | 415 / 430 |
| thymus | 100% | 800.04 | 652 / 653 | 94% | 17.64 | 567 / 605 |
| skin | 96% | 416.08 | 1730 / 1809 | 98% | 12.03 | 462 / 472 |
| bladder | 100% | 453.43 | 21 / 21 | 89% | 7.67 | 449 / 504 |
| breast | 90% | 406.43 | 414 / 459 | 96% | 12.83 | 1078 / 1118 |
| lung | 87% | 372.14 | 504 / 578 | 90% | 8.10 | 1041 / 1155 |
| uterus | 99% | 714.69 | 169 / 170 | 73% | 7.64 | 335 / 459 |
| stomach | 97% | 389.81 | 350 / 359 | 74% | 4.40 | 213 / 286 |
| intestine | 85% | 343.65 | 824 / 966 | 79% | 5.11 | 415 / 527 |
| esophagus | 76% | 311.55 | 1095 / 1445 | 63% | 4.30 | 116 / 183 |
| liver | 75% | 221.04 | 170 / 226 | 48% | 3.30 | 196 / 406 |
| eye | 0% | 0 | 0 / 0 | 100% | 11.46 | 80 / 80 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.89 | 1 / 1 |
| blood vessel | 94% | 341.70 | 1251 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 93% | 286.42 | 223 / 241 | 0% | 0 | 0 / 0 |
| heart | 92% | 474.10 | 794 / 861 | 0% | 0 | 0 / 0 |
| adipose | 74% | 223.49 | 894 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 51% | 3.03 | 23 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 45% | 1.91 | 13 / 29 |
| muscle | 35% | 86.81 | 283 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 14% | 40.78 | 128 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0048678 | Biological process | response to axon injury |
| GO_0042995 | Cellular component | cell projection |
| GO_0032433 | Cellular component | filopodium tip |
| GO_0032426 | Cellular component | stereocilium tip |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MORN4 |
| Protein name | MORN repeat-containing protein 4 (Protein 44050) (Retinophilin) MORN repeat containing 4 (MORN4 protein) MORN repeat-containing protein 4 |
| Synonyms | hCG_25157 C10orf83 |
| Description | FUNCTION: Plays a role in promoting axonal degeneration following neuronal injury by toxic insult or trauma. . FUNCTION: Plays a role in promoting axonal degeneration following neuronal injury by toxic insult or trauma. . |
| Accessions | Q8WVZ3 ENST00000370635.3 G3V1L7 Q8NDC4 ENST00000478953.1 ENST00000307450.11 [Q8NDC4-1] |
